FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:1533-1534 May 22, 1997 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by Suzanne Crowe, Jennifer Hoy, and John Mills. 437 pp., illustrated. New York, Cambridge University Press, 1996. $85. ISBN 0-521-45269-4.

Paradox in the emerging specialty of AIDS care is that the rapidity and complexity of changes in therapeutics have created the need for textbook-length compendiums of new information, yet the same pace of change risks making any such book less than up to date by the time it is published.

Dramatic changes in treatment have been particularly evident over the past year, with the management of HIV infection revolutionized in ways surpassing even the symbolic importance of the introduction of zidovudine in 1987 as the first HIV-specific antiretroviral agent. Quantitative plasma assays of viral load, combination antiretroviral therapy, and the . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.